Invion Limited
Invion Limited (IVIXF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IVIXF · as of Jun 9, 2026
Key Statistics
Explore Invion Limited Data
ivixf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ivixf competitorsIVIXF
ACUS
AQSZF
BLFE
CBDL
DVLPStock Performance
Full HistoryAbout Invion Limited
Invion Limited an Australian biopharmaceutical firm currently in the clinical development phase, is dedicated to pioneering light-activated therapies for a diverse range of cancers. Its leading thera…
what is invion limited · ivixf stock overview · invion limited company profile · who is invion limited ceo · ivixf OTC · invion limited headquarters · invion limited business segments
About Stock Overview & Key Data
Invion Limited (IVIXF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since May 17, 2013. As of the latest trading session, IVIXF stock price is $0.00, with a market capitalization of $174,538. The stock has returned -95.12% over the past 12 months and -95.12% year-to-date.
In fiscal year 2025, Invion Limited reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Invion Limited (IVIXF) stock price is $0.00. The stock is traded on OTC under the ticker symbol IVIXF. The 52-week range is $0.00 – $0.04.